bioMérieux, a global player in in vitro diagnostics and world leader in industrial microbiological control, announces the acquisition of Hyglos, a Bernried (Germany) - based company specializing in the detection of endotoxins.
bioMerieux and Sepsis Alliance co-sponsor the largest NC fundraiser designed to raise awareness on the importance of prevention through early detection of sepsis, the 10th Leading Cause of Death in the U.S.
bioMérieux and Sepsis Alliance announce collaboration on events to raise awareness, educate about the risk of sepsis, and share best practices with hospitals and physicians
Marcy l'Etoile (France), April 20, 2016 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016.
Huge discrepancies in antibiotic use practices between countries, 2nd line antibiotics2 too frequently prescribed
BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel FilmArray® Torch delivers high throughput, radically smaller footprint
bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce the first commercial success resulting from their alliance.
March 2, 2016 – The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met yesterday under the chairmanship of Jean-Luc Belingard and approved the consolidated financial statements for the year ended December 31, 2015.
FilmArray® Torch delivers high throughput, radically smaller footprint
State-of-the-art facility operated by leading health care firm, Cerner
